Biosimilars in clinical practice

被引:1
|
作者
Mikhail, Ashraf [1 ]
机构
[1] Univ Coll Swansea, Morriston Hosp, Renal Unit, Swansea SA6 6NL, W Glam, Wales
来源
关键词
D O I
10.1159/000107096
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
引用
收藏
页码:18 / 22
页数:5
相关论文
共 50 条
  • [31] Developing Clinical Trials for Biosimilars
    Bui, Lynne A.
    Taylor, Carrie
    SEMINARS IN ONCOLOGY, 2014, 41 (01) : S15 - S25
  • [32] Clinical trial development for biosimilars
    Alten, Rieke
    Cronstein, Bruce N.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 44 (06) : S2 - S8
  • [33] Clinical trials for trastuzumab biosimilars
    Derbyshire, Michelle
    GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2020, 9 (02): : 84 - 89
  • [34] European Stakeholder Learnings Regarding Biosimilars: Part II—Improving Biosimilar Use in Clinical Practice
    Liese Barbier
    Steven Simoens
    Arnold G. Vulto
    Isabelle Huys
    BioDrugs, 2020, 34 : 797 - 808
  • [35] Emerging Opportunities and Challenges of Biosimilars in Oncology Practice
    Lyman, Gary H.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (09) : 7S - +
  • [36] Biosimilars: Reimbursement Issues in Your Oncology Practice
    Conti, Rena M.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (09) : 12S - +
  • [37] Clinical considerations for the development of biosimilars in oncology
    Socinski, Mark A.
    Curigliano, Giuseppe
    Jacobs, Ira
    Gumbiner, Barry
    MacDonald, Judith
    Thomas, Dolca
    MABS, 2015, 7 (02) : 286 - 293
  • [38] Biosimilars: Policy, clinical, and regulatory considerations
    Gottlieb, Scott
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (14) : S2 - S8
  • [39] A Clinical Review of Biosimilars Approved in Oncology
    Ngo, Dat
    Chen, Jason
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (03) : 362 - 377
  • [40] Biosimilars: State of Clinical and Regulatory Science
    Klein, Agnes V.
    Wang, Jian
    Feagan, Brian G.
    Omoto, Mark
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2017, 20 : 332 - 348